These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice. Cruse JM, Lewis RE, Dilioglou S. Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362 [Abstract] [Full Text] [Related]
3. [Ultrastructural study on membranoproliferative glomerulonephritis with special reference to subepithelial deposits]. Sato H. Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):973-83. PubMed ID: 2263028 [Abstract] [Full Text] [Related]
10. The application of electron microscopic morphometry as helpful method in the diagnosis of focal segmental glomerulosclerosis (FSGS) early phase. I. Morphometric electron microscopic studies of renal glomeruli in cases of focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD) and mesangioproliferative glomerulonephritis (GNMES) in children. Woźniak A, Salwa-Zurawska W, Kaczmarek E, Bortkiewicz E, Gładysz J, Maciejewski J. Pol J Pathol; 2001 Jul; 52(1-2):27-36. PubMed ID: 11505678 [Abstract] [Full Text] [Related]
15. Mesangioproliferative glomerulonephritis in mink with encephalitozoonosis. Zhou Z, Nordstoga K. Acta Vet Scand; 1993 Jul; 34(1):69-76. PubMed ID: 8342467 [Abstract] [Full Text] [Related]
16. [Clinical pathology of the glomerulus--from phenomenon to entity. The mesangial lesion]. Gärtner HV, Greschniok A, Wehrmann M, Bogenschütz O, Oliveira V, Mall A, Junghans R, Mikeler E, Bohle A. Verh Dtsch Ges Pathol; 1989 Jul; 73():41-60. PubMed ID: 2482629 [Abstract] [Full Text] [Related]
17. Membranoproliferative glomerulonephritis with isolated C3 deposits: case report and literature review. Darouich S, Goucha R, Jaafoura MH, Zekri S, Kheder A, Ben Maiz H. Ultrastruct Pathol; 2011 Feb; 35(1):42-6. PubMed ID: 21265634 [Abstract] [Full Text] [Related]
18. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist. Ito S, Kuriyama H, Iino N, Iguchi S, Shimada H, Ueno M, Narita I, Nakano M, Nishi S, Karasawa R, Gejyo F. Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359 [Abstract] [Full Text] [Related]
19. [A case of mesangial proliferative glomerulonephritis with endothelial damage]. Miki Y, Shimizu H, Danbara A, Fujita Y, Ito Y, Matsuo S. Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):547-51. PubMed ID: 12476592 [Abstract] [Full Text] [Related]
20. In situ complement activation in porcine membranoproliferative glomerulonephritis type II. Jansen JH, Høgåsen K, Harboe M, Hovig T. Kidney Int; 1998 Feb; 53(2):331-49. PubMed ID: 9461093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]